TP53
Clinical trials for TP53 explained in plain language.
Never miss a new study
Get alerted when new TP53 trials appear
Sign up with your email to follow new studies for TP53, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stem cell method may cut transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests a new way to prepare donor stem cells for transplant in people with blood cancers like leukemia. By removing certain immune cells from the donated cells, researchers hope to lower the risk of graft-versus-host disease, a serious side effect. The study involves 70…
Matched conditions: TP53
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New drug combo aims to keep endometrial cancer at bay
Disease control Recruiting nowThis study tests whether a combination of two drugs, abemaciclib and letrozole, can help keep advanced or recurrent endometrial cancer from growing. The trial enrolls 32 people with a specific type of cancer that is estrogen-receptor positive and has certain genetic features. Par…
Matched conditions: TP53
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New hope for aggressive lymphoma with gene mutation?
Disease control Recruiting nowThis study tests a combination of three drugs (glofitamab, a PD-1 inhibitor, and lenalidomide) in 24 people with a type of large B-cell lymphoma that has returned or not responded to treatment and has a specific gene change (TP53). The goal is to see if this combination can shrin…
Matched conditions: TP53
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC